DSGN · Forms 3, 4, 5
Insider trades at Design Therapeutics, Inc.
No open-market insider buys or sells at Design Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Design Therapeutics, Inc. (DSGN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Design Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Simeon George | Director | Options or other derivatives | Form 4 | ||||
| John P. Schmid | Director | Options or other derivatives | Form 4 | ||||
| Rodney W Lappe | Director | Options or other derivatives | Form 4 | ||||
| Justin D. Gover | Director | Options or other derivatives | Form 4 | ||||
| David Shapiro | Director | Options or other derivatives | Form 4 | ||||
| Heather A. Berger | Director | Options or other derivatives | Form 4 | ||||
| David Shapiro | Director | Options or other derivatives | Form 4 | ||||
| David Shapiro | Director | Became an insider (Form 3) | Form 3 | ||||
| Chris Storgard | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Sean Jeffries | Chief Operating Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.